Overexpression of oncoprotein MDM2 has been found in a signi®cant number of human soft tissue tumors. In a subset of these tumors, overexpression is a result of enhanced translation of mdm2 mRNA. There are two transcripts from the mdm2 gene that dier only in their 5' leaders: a long form (L-mdm2) and a short form (Smdm2) that arise from the use of dierent promoters. Lmdm2 mRNA contains two upstream open reading frames (uORFs) and this mRNA was loaded with ribosomes ineciently in comparison with S-mdm2. The 5' leader of L-mdm2 was sucient to transfer translational repression to a reporter gene and the two uORFs acted synergistically to achieve full suppression. In contrast, the 5' leader of S-mdm2 allowed ecient translation of an attached reporter gene in the tumor cells. These results are consistent with a model in which overexpression of MDM2 in certain tumors results from a change in mRNA structure due to a switch in promoter usage.
Introduction
Oncoprotein MDM2 is overexpressed in a number of human tumors, particularly in osteosarcomas, soft tissue sarcomas and gliomas (Oliner et al., 1992; Ladanyi et al., 1993; Leach et al., 1993; Reifenberger et al., 1993; Cordon-Cardo et al., 1994) . One function of MDM2 is to interact with and antagonize the activity of p53 (Momand et al., 1992; Barak and Oren, 1993; Oliner et al., 1992) by inhibiting p53-dependent transactivation of target genes (Momand et al., 1992) and p53-dependent suppression of transformed cell growth (Finlay et al., 1993) . DNA damage up-regulates p53 activity, which in turn activates transcription of MDM2. When bound by MDM2, p53 is targeted for degradation through the ubiquitin-proteasome pathway (Haupt et al., 1997; Kubbutat et al., 1997) . This negative feedback loop (Wu et al., 1993; Barak et al., 1994) is thought to limit the growth suppressive activities of p53. The role of p53 in maintaining the integrity of the genome in response to DNA damage Diller et al., 1990; Martinez et al., 1991; Kastan et al., 1991) explains the oncogenic result of MDM2 overexpression and the biological requirement for tight regulation of MDM2 expression.
In some human tumors, overexpression of MDM2 protein does not result from elevated mdm2 mRNA levels or from enhanced stability of the protein, but is a consequence of increased translation of MDM2 (Landers et al., 1994 (Landers et al., , 1997 Capoulade et al., 1998) . Previous studies have shown that transcription of the mdm2 gene can arise from one of two promoters (Wu et al., 1993; Juven et al., 1993; Zauberman et al., 1995) yielding, in humans, alternatively spliced mRNAs that are identical except for their 5' leaders. Transcription from the ®rst promoter, designated P1, yields an mRNA with Exon 2 spliced out ( Figure 1 , L-mdm2). Transcription from this promoter is not induced by p53 and seems to result in low constitutive levels of MDM2 protein. Conversely, transcription from the internal P2 promoter (Barak et al., 1994) arises as a consequence of binding by p53 to response elements residing in Intron 1 of the mdm2 gene (Juven et al., 1993; Wu et al., 1993) . Activation of this promoter by p53 results in synthesis of an mRNA containing Exon 2, but lacking Exon 1 (Figure 1 , S-mdm2). Transcription from the P2 promoter is elevated approximately sixfold relative to P1 in tumor cells overexpressing MDM2 by increased translation (Landers et al., 1997) .
One interpretation of these observations is that transcripts derived from the P1 promoter are translationally repressed and that a switch to the P2 promoter makes available transcripts that are more actively translated. The studies reported here were designed to test this hypothesis. Inspection of the sequence of the`long form' of mdm2 mRNA (Lmdm2), which contains the 5' leader derived from Exon 1, revealed the presence of two upstream open reading frames (uORFs). uORFs occur frequently in oncogenes and in some cases have been shown to regulate translation (Geballe and Morris, 1994; Geballe, 1996; Morris, 1997) . In the present study, we show that the two uORFs in L-mdm2 are responsible for inecient translation of this form of mdm2 mRNA. Furthermore, we show that the`short form' of mdm2 mRNA (Smdm2), which is elevated in those tumors demonstrating increased MDM2 protein due to enhanced translation, is eciently translated in the tumor cells.
were displayed in sucrose gradients and fractions from these gradients were analysed by RNase protection, using a probe that distinguishes between the L-mdm2 and S-mdm2 transcripts (Materials and methods). An autoradiograph of the primary data from the choriocarcinoma cell line JAR is shown in Figure 2 . The protected fragments corresponding to L-mdm2 (ca. 500 nucleotides) and S-mdm2 (196 nucleotides) are well resolved. Furthermore, it is clear that the bulk of the polysomes containing S-mdm2 mRNA sediment more rapidly than those carrying L-mdm2. For subsequent analysis, the RNase protection results were quanti®ed by phosphorimage analysis and the data presented graphically.
We examined ribosome loading on the two species of mdm2 mRNA by this method in the choriocarcinoma cell lines, JEG-3 and JAR. The control cell lines chosen, HeLa cells and MRC-5 normal human lung ®broblasts, both produce low levels of wild type p53 (Landers et al., 1997; Butz et al., 1995) . In the two choriocarcinoma cell lines, JAR and JEG-3, the majority of the L-mdm2 transcripts was con®ned to polysomes containing four ribosomes or less (Figure 3a and b). This relatively poor loading with ribosomes is consistent with the prediction that the L-mdm2 mRNA would be poorly translated (Landers et al., 1997) . In contrast, a signi®cant fraction of S-mdm2 mRNA was loaded with ®ve or more ribosomes (Figure 3a and b) , consistent with this mRNA species being well translated. These results con®rm the hypothesis (Landers et al., 1997) that one element of the overexpression of MDM2 observed in these tumors is related to the elevated ratio of the short to long forms of the mdm2 transcripts.
A dierent pro®le of mdm2 transcripts in polysomes was observed in HeLa and MRC-5 cells. In these cell lines, L-mdm2 mRNA was con®ned mainly to small polysomes (Figure 3c and d) , similar to the situation in JEG-3 and JAR cells. However, in clear contrast to the choriocarcinoma cells, S-mdm2 mRNA in both MRC-5 and HeLa cells tracked in a pattern very similar to that of L-mdm2. This result suggested that both species of mdm2 mRNA are translated poorly in HeLa and MRC-5 cells, in contrast to the tumor cells where Smdm2 was more eciently loaded with ribosomes than L-mdm2.
Translation state of the mdm2 mRNAs is dictated in part by the structures of the 5' leaders Chimeric genes were constructed in which the 5' leader of human growth hormone (hGH) was replaced with the 5' leaders of the two mdm2 mRNAs (Materials and methods). To test the translational activities of these two 5' leaders, HeLa and JEG-3 cells were stably transfected with these constructs and translational eciency was determined by measuring rates of hGH production, normalized to the level of mRNA expression (Materials and methods). As a control, the 5' leader of S-mdm2 (Exon 2) was cloned into the expression vector in the reverse orientation (resulting in construct pGH-E2R). The expression results, expressed as a fraction of the translational eciency of pGH-E2R, are presented in Table 1 . The eciency of translation from construct pGH-E2, which contains the 5' leader of S-mdm2 in the correct orientation, is approximately equal to that from the control pGH-E2R construct in both cell lines. This observation argues that there are no sequence-speci®c translational control elements located within the S-mdm2 5' leader. In contrast, the 5' leader of L-mdm2 mRNA (in construct pGH-E1) suppressed hGH expression to less than 5% of that of pGH-E2, suggesting that sequences inhibitory to translation are present in the 5' leader derived from Exon 1. This conclusion was supported by the observation that deleting 200 of the 287 nucleotides of the 5' leader of pGH-E1, yielding construct pGH-E1D200 (Figure 4) , elevated translational eciency by 10 ± 20-fold (Table 1) .
The conclusion that the 5' leader contained sequences that are suppressive was con®rmed by analysis of polysome pro®les. In both HeLa ( Figure  5a ) and JEG-3 (Figure 5b ) cells, presence of the 5' leader of L-mdm2 in construct pGH-E1 resulted in an mRNA that was asssociated primarily with monosomes and small polysomes, consistent with poor translation. In contrast, the mRNA derived from construct pGH-E1D200, in which 200 nucleotides had been deleted from the L-mdm2 5' leader, extended into larger polysomes, indicating more ecient translation. These results are consistent with the results from hGH protein expression and demonstrate that sequences in the L-mdm2 5' leader imposed translational repression on an otherwise well-translated mRNA.
Two uORFs act to repress translation of L-mdm2 mRNA
The preceding experiments showed that deletion of 200 nucleotides from the 5' leader of L-mdm2 mRNA alleviated the strong translational repression imposed by sequences or structures present in this region of the messenger RNA. Two 15-codon uORFs present in Lmdm2 were good candidates for translational control elements. A single base change (AUG to AAG) was introduced into the initiation codons of the two uORFs (see Figure 4 for diagrams of the resulting constructs) and these altered 5' leaders were inserted into the hGH expression plasmid. The translational eciency of the resulting transcripts were examined in stably transfected HeLa and JEG-3 cells ( Table 2 ). The results in Figure 3 Pro®les of ribosome loading on L-mdm2 (*) and S-mdm2 (*) mRNAs. Extracts were prepared from JAR (a), JEG-3 (b), MRC-5 (c) and HeLa (d) cells and displayed by sucrose gradient centrifugation. The direction of sedimentation was from left to right. The relative amounts of L-mdm2 and S-mdm2 mRNA in each fraction were determined by RNase protection as in Figure 2 and expressed as the percentage of the sum of the signals for each species in the twelve fractions. During fractionation, polysome pro®les were monitored with a simultaneous A 254 trace; the positions of the fractions containing monosomes and polysomes containing ®ve ribosomes, respectively, are indicated as`80S' and`5-mer' on the ®gure Table 2 are expressed relative to the construct with both uORFs disabled (pGH-E1DU1,2), which had a translational eciency approximately equal to that of the well translated pGH-E2 construct (data not shown). The presence of both uORFs in construct pGH-E1 suppressed translation 10 ± 20-fold in both cell types. In HeLa cells, inactivation of either uORF singly (pGH-E1DU1 and pGH-E1DU2) elevated hGH translation to nearly that of pGH-E1DU1,2. Therefore, each uORF by itself inhibited translation only weakly, suggesting that the uORFs act synergistically to elicit the strong inhibition observed with the wild type Lmdm2 leader. With JEG-3 cells, the same general picture emerged, with one subtle dierence. Removal of uORF2, resulting in construct pGH-E1DU2, had a much less profound eect on translational eciency, compared to pGH-E1, than that observed in HeLa cells. This result indicates that uORF1, when present by itself, is more inhibitory in JEG-3 than in HeLa cells.
The hGH expression results were con®rmed by analysis of polysome pro®les. In HeLa cells ( Figure  6a ), all three mutant constructs (pGH-E1DU1, pGH-E1DU2 and pGH-E1DU1,2) increased ribosome loading to the same extent relative to the construct with the wild type L-mdm2 5' leader. It therefore seems that both uORFs must cooperate to obtain strong translational suppression in HeLa cells, since neither uORF by itself suppressed ribosome loading to a detectable extent. In the choriocarcinoma cell line, JEG-3 (Figure 6b ), pGH-E1DU2 was only slightly enhanced relative to the construct with the intact Lmdm2 5' leader (pGH-E1), consistent with the hGH expression result showing that uORF1 signi®cantly suppressed translation by itself. Construct pGH-E1DU1 was intermediate in behavior between that of the construct containing the wild type 5' leader (pGH-E1) and that with both uORFs inactivated (pGH-E1DU1,2). These polysome loading patterns graphically demonstrate the dierence between the two cell types in interactions between the two uORFs: translational activity is de®ned by synergistic interaction in HeLa cells, in contrast to additive inhibition by the two uORFs in JEG-3 cells. Figure 5 Ribosome loading on the pGH-E1 (*) and pGH-E1D200 (*) constructs in HeLa (a) and JEG-3 (b) cells. Other details are as described in the legend to Figure 3 
Discussion
Studies of two choriocarcinoma lines that overexpress MDM2 protein have suggested that increased translation, rather than elevated mRNA level, is responsible for a substantial fraction of the increased expression of MDM2 (Landers et al., 1994 (Landers et al., , 1997 . In these tumors, there is a transcriptional switch from use of the P1 to the P2 promoter, yielding enhanced cellular levels of the S-mdm2 isoform of mdm2 mRNA relative to Lmdm2 (Landers et al., 1997) . These previous studies led to the hypothesis that S-mdm2 mRNA is more eciently translated than the L-mdm2 form, contributing largely to the observed elevated MDM2 translation (Landers et al., 1997) . One of the goals of the current study was to test this hypothesis through analysis of ribosome loading on endogenous mdm2 transcripts derived from the two promoters. The conclusions from these experiments are quite clear. While the S-mdm2 transcript in the overproducing tumor cells was eciently loaded with ribosomes, the L-mdm2 transcript was predominantly associated with only a few ribosomes, consistent with inecient translation. Analysis of chimeric constructs demonstrated that this dierence in translatability of the two constructs was associated with inhibitory elements in the 5' leader of L-mdm2 mRNA, rather than stimulatory elements in the S-mdm2 leader. The S-mdm2 leader had the same ecient translational properties when placed in the forward and reverse directions, and approximately the same translational eciency (data not shown) as the well-translated 5' leader of the hGH mRNA (Hill and Morris, 1992) . In contrast, deletions or point mutations in the L-mdm2 leader stimulated ribosome loading, resulting in elevated translation, consistent with the presence of inhibitory structures.
In HeLa and MRC-5 cells, L-mdm2 was inefficiently loaded with ribosomes, as in the choriocarcinoma cells. Surprisingly, ribosome loading on the endogenous S-mdm2 mRNA was also inecient, in contrast to ecient loading on this mRNA in the overexpressing tumor cells. Since translation of the chimeric construct containing the 5' leader of S-mdm2 was equally ecient in all four cell lines, it seems that the structural element(s), conferring poor translation on the endogenous S-mdm2 mRNA in HeLa and MRC-5 cells may be located, at least in part, elsewhere in the molecule. This result suggests that some property of the choriocarcinoma cells, in addition to the switch from P1 to P2 promoter, may contribute to the observed enhancement of MDM2 translation.
The presence of one or more uORFs, although rare in mRNAs generally, is a common occurrence in oncogenes and other genes related to cell growth control (Geballe and Morris, 1994; Geballe, 1996) . As a general rule, single uORFs, by themselves, weakly inhibit translation in mammalian cells by only 10 ± 40% (Mize et al., 1998) . Strong inhibitory activity can be conferred on a single uORF by special amino acid sequences in the encoded peptide or by the context of nucleotide sequence surrounding the termination codon (Geballe and Morris, 1994; Geballe, 1996) . In the case of the individual mdm2 uORFs, the inhibitory activities were quite modest, with the exception of uORF1 in JEG-3 cells. uORF2 in HeLa or JEG-3 cells, or uORF1 in HeLa cells, produced no more than 40% inhibition when present individually. Interestingly, in HeLa cells, there seems to be a strong synergism between uORF1 and uORF2 that gave greater than 95% inhibition, which is far more than expected for an additive in¯uence of the two uORFs. This synergism appears to be cell-speci®c, since inhibition by the uORFs seems to be additive in JEG-3 cells.
The mdm2 gene will provide a valuable system for studying regulation by multiple uORFs in mammalian cells. To date, there is only one well-de®ned model for synergistic interaction between multiple uORFs in eukaryotic cells. The GCN4 gene in yeast has four functional uORFs that interact to make translation of this gene responsive to the availability of amino acids (Hinnebusch, 1996) . Synergism between the GCN4 uORFs is through reinitiation combined with regulated leaky-scanning and is modulated by the phosphorylation state of initiation factor eIF-2. Although eIF-2 kinases have been de®ned in mammalian cells (Clemens, 1996) , it would be premature at this point to suggest that this mechanism is involved in regulating the synergism between the mdm2 uORFs. 
Materials and methods

Cell culture
Choriocarcinoma cell lines, JEG-3 and JAR were cultured in DMEM supplemented with 10% fetal calf serum. HeLa cells were maintained in DMEM supplemented with 10% calf serum. MRC-5 cells were grown in DMEM supplemented with 10% fetal calf serum, 5 mM L-glutamine, 1 mM sodium pyruvate and 0.1 mM non-essential amino acids. All media were supplemented with penicillin (100 units per ml) and streptomycin (50 mg per ml).
HeLa cells were transfected using a standard calcium phosphate precipitation procedure (Ausubel, 1993) . JEG-3 cells were transfected using Lipofectamine (GIBCO ± BRL Life Technologies, Gathersberg, MD, USA) by incubating 0.5610 6 cells for 3 h in 10 ml culture medium with 10 mg DNA and 35 ml lipofectamine stock reagent. Cells carrying transfected DNA were selected in the presence of G418 (400 mg/ml) and clones (50 ± 200) were pooled.
Construction of chimeric constructs
The control plasmid containing the full hGH 5' leader (pRNN) was described previously (Hill and Morris, 1992) . The construct containing the 5' leader of L-mdm2 (pGH-E1) was generated by inserting a PCR ampli®ed 287-nucleotide fragment of Exon 1 with incorporated 5' and 3' BamHI restriction sites, into the BamHI site of pD5'GH-RNN as described previously (Hill and Morris, 1992) . Six extra nucleotides were added to facilitate digestion by BamHI. The primers were (BamHI site underlined): upper strand (nucleotides 1 ± 18): 5'-CGGCATGGATCC-GCACCGCGGCGAGCTTGG-3' and lower strand (nucleotides 271 ± 287); 5'-CGAGTGGGATCCCCGGGGTTTTC-GCGCTTG-3'. The resulting construct contained all of Exon 1, except for ten nucleotides at 3' end.
Construct pGH-E1D200 was created by PCR ampli®cation of the L-mdm2 5' leader minus the initial 200 nucleotides. The upper strand primer (nucleotides 200 ± 217) was 5'-CGGCATGGATCCGAGGCCCAGGGCGTCGTG-3'. The lower strand primer was that used above for the full-length Exon 1 ampli®cation.
The constructs containing altered start codons of the uORFs were generated by PCR ampli®cation with Pfu polymerase (Stratagene, La Jolla, CA, USA) of the entire plasmid containing the Exon 1 fragment from construct pGH-E1 (Hemsley et al., 1989) . For production of the 5' leader of pGH-E1DU1, the upper strand primer (nucleotides 47 ± 67) was: 5'-GTGTCGGAAAGAAGGAGCAAGA-3' and the lower strand primer (24 ± 46) was 5'-ACAGGGCCA-CACAGGCCCCAGA-3'. The 5' leader of pGH-E1DU2 was generated using the upper strand primer (nucleotides 180 ± 201) 5'-CGGAGAGTGGAAAGATCCCCGA-3' and the lower strand primer (158 ± 179) 5'-GGCCAGGG-CACTGGGCGCTCGTA-3'. The double mutant (pGH-E1DU1,2) was generated by taking the pGH-E1DU1 5' leader and re-amplifying it by PCR using the primers that were used to generate pGH-E1DU2. The structures of the modi®ed Exon 1 fragments were con®rmed by sequence analysis and cloned into the BamHI site of pD5'GH-RNN, yielding the ®nal expression constructs.
Constructs pGH-E2 and pGH-E2R were generated by annealing oligonucleotides corresponding to the full length of Exon 2, incorporating BamHI restriction sites at the 5' and 3' ends and ligating the annealed double stranded oligonucleotide into the BamHI site of construct pD5'GH-RNN.
Isolation of cellular and polysomal RNA
Total RNA was isolated by the guanidine thiocyanate lysis procedure of Chomczynski and Sacchi (1987) . The amount isolated was calculated from the A 260 .
For isolation of polysomes, two 15-cm 2 tissue culture plates were seeded with JAR, JEG-3 or HeLa cells and nine 15-cm 2 seeded with MRC-5 cells. Cells were grown to near con¯uence, harvested by incubation with trypsin (in the presence of 100 mg cyclohexamide per ml), washed in phosphate-buered saline with cycloheximide and the trypsin was then inactivated with phenylmethylsulfonyl¯uoride (1 mM). The cells were collected by centrifugation at 1000 g at 48C and washed in phosphate-buered saline containing cycloheximide. Lysates were prepared, centrifuged through a 0.5 ± 1.5 M sucrose gradient and separated into 12 fractions as previously described (Ruan et al., 1997) . RNA was isolated from the fractions for subsequent analysis.
RNase protection assays
For analysis of mdm2 transcripts derived from the P1 and P2 promoters, a probe was prepared from the 5' RACE-PCR product of L-mdm2 (Landers et al., 1997) that contains all of the 5' leader of L-mdm2 (Exon 1) and 196 nucleotides of Exon 3. L-mdm2 mRNA protects approximately 500 nucleotides of the riboprobe (Exon 1 plus the Exon 3 fragment) and S-mdm2 mRNA protects only the 196-nucleotide fragment of Exon 3. The full-length riboprobe transcript contains in addition 132 nucleotides of polylinker sequence. The details of probe preparation, hybridization and RNase digestion are described in Ruan et al. (1997) . After RNase digestion, the protected fragments were resolved by electrophoresis in 6% polyacrylamide gel, visualized using a phosphorimager and quantitated using Imagequant version 3.21 (Molecular Dynamics, Sunnyvale, CA, USA).
The transcripts from the chimeric hGH constructs were analysed by RNase protection (Ruan et al., 1997 ) using a 389 base pair fragment of hGH.
Human growth hormone (hGH) assay
The hGH assay was carried out on samples of culture medium as described (Hill and Morris, 1992) , using a radioimmuno assay from Nichols Institute Diagnostic (San Juan Capistrano, CA, USA). In order to obtain translational eciency, hGH and RNase protection assays were performed using material from the same cultures. All assays were repeated at least three independent times.
